| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/06/2002 | WO2002068927A2 Using viruses to detect or purify proteins |
| 09/06/2002 | WO2002068677A2 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer |
| 09/06/2002 | WO2002068676A2 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 09/06/2002 | WO2002068665A2 Constitutive promoter from arabidopsis |
| 09/06/2002 | WO2002068658A1 Method for producing alpha-hydroxy acid, glycolic acid 2-hydroxyisobutyric acid from a corresponding alpha-hydroxy nitrile using nitrilase |
| 09/06/2002 | WO2002068653A2 Tri-hybrid melanoma antigen |
| 09/06/2002 | WO2002068650A2 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | WO2002068642A1 A novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 09/06/2002 | WO2002068635A2 Methods of inhibiting expression of a target gene in mammalian cells |
| 09/06/2002 | WO2002068632A2 Methods to identify mutant cells with altered sialic acid |
| 09/06/2002 | WO2002068627A2 Vector constucts |
| 09/06/2002 | WO2002068625A2 Packaging cell line for lentiviral vectors |
| 09/06/2002 | WO2002068617A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/06/2002 | WO2002068615A2 Activation of lymphocyte populations expressing nkg2d using anti-nkg2d antibodies and ligand derivatives |
| 09/06/2002 | WO2002068614A2 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 09/06/2002 | WO2002068605A2 Non-oligomerizing tandem fluorescent proteins |
| 09/06/2002 | WO2002068603A2 Materials and methods for the induction of premature chromosome condensation |
| 09/06/2002 | WO2002068600A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 09/06/2002 | WO2002068599A2 Retinoid inducible proteins of vascular smooth muscle cells and uses thereof |
| 09/06/2002 | WO2002068597A2 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | WO2002068594A2 Opiate receptors |
| 09/06/2002 | WO2002068589A2 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | WO2002068585A2 Tip39 polypeptides |
| 09/06/2002 | WO2002068583A2 Enzymes having dehalogenase activity and methods of use thereof |
| 09/06/2002 | WO2002068470A2 Interferon-alpha induced gene |
| 09/06/2002 | WO2002068463A1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 09/06/2002 | WO2002068459A2 Non aggregating fluorescent proteins and methods for using the same |
| 09/06/2002 | WO2002068436A1 Avilamycin derivatives |
| 09/06/2002 | WO2002068386A2 Tools and methods for identifying ppar$g(d)-specific agonists and antagonists |
| 09/06/2002 | WO2002067978A1 Chondrogenic potential of human bone marrow-derived cd105+ cells by bmp |
| 09/06/2002 | WO2002067970A1 TRYPTOPHANYL-tRNA SYNTHETASE DERIVED POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 09/06/2002 | WO2002067964A1 Compositions and methods for cancer prevention and treatment derived from $i(inula britannica) |
| 09/06/2002 | WO2002067957A1 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 09/06/2002 | WO2002067867A2 Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair |
| 09/06/2002 | WO2002067863A2 Tolerogenic antigen presenting cells and in treating immune-inflammatory conditions |
| 09/06/2002 | WO2002067862A2 Regulation of the ctl response by macrophage migration inhibitory factor |
| 09/06/2002 | WO2002067857A2 Modified annexin proteins and methods for preventing thrombosis |
| 09/06/2002 | WO2002067856A2 Injection molding of living tissues |
| 09/06/2002 | WO2002067812A2 Tympanic membrane patch |
| 09/06/2002 | WO2002067764A2 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
| 09/06/2002 | WO2002067762A2 Muscle-polymer constructs for bone tissue engineering |
| 09/06/2002 | WO2002067669A2 Primordial germ cell-based germ line production of birds |
| 09/06/2002 | WO2002067665A2 Cloning of transgenic animals comprising artificial chromosomes |
| 09/06/2002 | WO2002048182A3 Interferon-alpha induced gene |
| 09/06/2002 | WO2002046216A3 Human sprouty-4 polypeptide |
| 09/06/2002 | WO2002038735A3 Two chamber cell culture vessel |
| 09/06/2002 | WO2002036792A3 Dna expression vectors |
| 09/06/2002 | WO2002036771A3 Imaging, diagnosis and treatment of disease |
| 09/06/2002 | WO2002034923A3 Monocotyledon plant cells and plants which synthesise modified starch |
| 09/06/2002 | WO2002034889A3 Therapeutic uses for mesenchymal stromal cells |
| 09/06/2002 | WO2002032331A3 Microstructures for treating and conditioning skin |
| 09/06/2002 | WO2002010348A3 Tissue implant for cartilage repair |
| 09/06/2002 | WO2002010217A3 Endothelial cell expression patterns |
| 09/06/2002 | WO2002002629A3 Grf2-binding proteins and applications thereof |
| 09/06/2002 | WO2002000879A3 Methods for producing modified glycoproteins |
| 09/06/2002 | WO2001098334A3 Streptococcus antigens |
| 09/06/2002 | WO2001092479A3 Method to determine the differentiation potential of a target cell |
| 09/06/2002 | WO2001091805A3 Compounds for targeting endothelial cells |
| 09/06/2002 | WO2001085785A3 Ph domain-interacting protein |
| 09/06/2002 | WO2001073093A3 Cell-specific adenovirus vectors comprising an internal ribosome entry site |
| 09/06/2002 | WO2001072822B1 Genes involved in intestinal inflammatory diseases and use thereof |
| 09/06/2002 | WO2001064738A3 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/06/2002 | WO2001058915A8 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 09/06/2002 | WO2001032614A9 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 09/06/2002 | WO2001031021A9 Multiple sclerosis-related superantigen |
| 09/06/2002 | WO2001030851A9 Idiotype vaccines |
| 09/06/2002 | WO2001023531A9 Recognition of differences in cell cycle structure between stem and differentiated cells |
| 09/06/2002 | WO2001018035A9 Muc-1 derived peptides |
| 09/06/2002 | WO2001014529A9 Compositions and methods for improved cell culture |
| 09/06/2002 | WO2001012674A9 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 09/06/2002 | WO2001007627A9 Drosophila recombination-associated protein and methods for use |
| 09/06/2002 | WO2001007059A9 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 09/06/2002 | WO2001005945A9 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 09/06/2002 | WO2001005944A9 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 09/06/2002 | WO2001004334A9 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 coxsacki adenovirus receptor (car) |
| 09/06/2002 | WO2000078920A9 Methods and devices for cell culturing and organ assist systems |
| 09/06/2002 | WO2000067761A9 Compositions and methods for identifying antigens which elicit an immune response |
| 09/06/2002 | WO2000065062A9 Genome sequence and polypeptides of pyrococcus abissy, fragment and uses thereof |
| 09/06/2002 | CA2846761A1 Enzymes having dehalogenase activity and methods of use thereof |
| 09/06/2002 | CA2833423A1 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | CA2756609A1 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 09/06/2002 | CA2674673A1 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | CA2477043A1 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer |
| 09/06/2002 | CA2439492A1 Tri-hybrid melanoma antigen |
| 09/06/2002 | CA2439472A1 Methods and compositions for modifying apolipoprotein b mrna editing |
| 09/06/2002 | CA2439400A1 Non-oligomerizing tandem fluorescent proteins |
| 09/06/2002 | CA2439383A1 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 09/06/2002 | CA2439335A1 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 09/06/2002 | CA2439185A1 Vector constructs |
| 09/06/2002 | CA2439175A1 Opiate receptors |
| 09/06/2002 | CA2439150A1 Avilamycin derivatives |
| 09/06/2002 | CA2438934A1 Chondrogenic potential of human bone marrow-derived cd105+ cells by bmp |
| 09/06/2002 | CA2438932A1 Compositions and methods for cancer prevention and treatment derived from inula britannica |
| 09/06/2002 | CA2438884A1 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | CA2438832A1 Transgenic knockouts of bace-1 |
| 09/06/2002 | CA2438827A1 Retinoid inducible proteins of vascular smooth muscle cells and uses thereof |
| 09/06/2002 | CA2438617A1 Cloning of transgenic animals comprising artificial chromosomes |
| 09/06/2002 | CA2438612A1 Primordial germ cell-based germ line production of birds |
| 09/06/2002 | CA2438406A1 Materials and methods for the induction of premature chromosome condensation |
| 09/06/2002 | CA2438273A1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of angiogenesis |